Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zevra Therapeutics (ZVRA) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Zevra Therapeutics (ZVRA) over the last 11 years, with Q3 2025 value amounting to $2.3 million.

  • Zevra Therapeutics' Interest & Investment Income rose 12049.57% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year increase of 10996.75%. This contributed to the annual value of $2.2 million for FY2024, which is 5210.31% down from last year.
  • Latest data reveals that Zevra Therapeutics reported Interest & Investment Income of $2.3 million as of Q3 2025, which was up 12049.57% from $2.4 million recorded in Q2 2025.
  • Over the past 5 years, Zevra Therapeutics' Interest & Investment Income peaked at $2.4 million during Q2 2025, and registered a low of -$73000.0 during Q4 2024.
  • Moreover, its 5-year median value for Interest & Investment Income was $278000.0 (2022), whereas its average is $733421.1.
  • As far as peak fluctuations go, Zevra Therapeutics' Interest & Investment Income surged by 1253333.33% in 2022, and later tumbled by 13476.19% in 2024.
  • Quarter analysis of 5 years shows Zevra Therapeutics' Interest & Investment Income stood at $125000.0 in 2021, then surged by 122.4% to $278000.0 in 2022, then decreased by 24.46% to $210000.0 in 2023, then crashed by 134.76% to -$73000.0 in 2024, then soared by 3268.49% to $2.3 million in 2025.
  • Its Interest & Investment Income was $2.3 million in Q3 2025, compared to $2.4 million in Q2 2025 and $543000.0 in Q1 2025.